Zarredar H - Search Results

1

Overview of CD24 as a new molecular marker in ovarian cancer.

Tarhriz V, Bandehpour M, Dastmalchi S, Ouladsahebmadarek E, Zarredar H, Eyvazi S. Tarhriz V, et al. Among authors: zarredar h. J Cell Physiol. 2019 Mar;234(3):2134-2142. doi: 10.1002/jcp.27581. Epub 2018 Oct 14. J Cell Physiol. 2019. PMID: 30317611 Review.

2

Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update.

Eyvazi S, Farajnia S, Dastmalchi S, Kanipour F, Zarredar H, Bandehpour M. Eyvazi S, et al. Among authors: zarredar h. Curr Cancer Drug Targets. 2018;18(9):857-868. doi: 10.2174/1568009618666180102102311. Curr Cancer Drug Targets. 2018. PMID: 29295696 Review.

3

Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications.

Zarredar H, Ansarin K, Baradaran B, Shekari N, Eyvazi S, Safari F, Farajnia S. Zarredar H, et al. Anticancer Agents Med Chem. 2018;18(14):1991-2005. doi: 10.2174/1871520618666180808125459. Anticancer Agents Med Chem. 2018. PMID: 30088452 Review.

4

Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro.

Zarredar H, Pashapour S, Ansarin K, Khalili M, Baghban R, Farajnia S. Zarredar H, et al. J Cell Physiol. 2019 Feb;234(2):1560-1566. doi: 10.1002/jcp.27021. Epub 2018 Aug 21. J Cell Physiol. 2019. PMID: 30132854

5

Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor.

Zarredar H, Pashapour S, Farajnia S, Ansarin K, Baradaran B, Ahmadzadeh V, Safari F. Zarredar H, et al. J Cell Biochem. 2019 Jun;120(6):10670-10677. doi: 10.1002/jcb.28357. Epub 2019 Jan 17. J Cell Biochem. 2019. PMID: 30656741

6

Anticancer Impacts of Terminalia catappa Extract on SW480 Colorectal Neoplasm Cell Line.

Shanehbandi D, Zarredar H, Asadi M, Zafari V, Esmaeili S, Seyedrezazadeh E, Soleimani Z, Sabagh Jadid H, Eyvazi S, Feyziniya S, Moghadam SB, Khalili M. Shanehbandi D, et al. Among authors: zarredar h. J Gastrointest Cancer. 2021 Mar;52(1):99-105. doi: 10.1007/s12029-019-00349-z. J Gastrointest Cancer. 2021. PMID: 31823219

7

Long non-coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis.

Aftabi Y, Ansarin K, Shanehbandi D, Khalili M, Seyedrezazadeh E, Rahbarnia L, Asadi M, Amiri-Sadeghan A, Zafari V, Eyvazi S, Bakhtiyari N, Zarredar H. Aftabi Y, et al. Among authors: zarredar h. IUBMB Life. 2021 Feb;73(2):307-327. doi: 10.1002/iub.2430. Epub 2020 Dec 24. IUBMB Life. 2021. PMID: 33369006 Free article. Review.

8

Down-regulation and Clinic-pathological Correlation of SIK-1 and SIK-1-LNC in Non-small Cell Lung Cancer Patients.

Anvarnia A, Panahizadeh R, Zarredar H, Asadi M, Hashemzadeh S, Vatankhah MA, Valizadeh H, Raeisi M. Anvarnia A, et al. Among authors: zarredar h. Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1407-1411. doi: 10.31557/APJCP.2023.24.4.1407. Asian Pac J Cancer Prev. 2023. PMID: 37116165 Free PMC article.

9

Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology.

Zarredar H, Ansarin K, Baradaran B, Ahdi Khosroshahi S, Farajnia S. Zarredar H, et al. Cancer Invest. 2018 Jan 2;36(1):37-58. doi: 10.1080/07357907.2017.1416393. Epub 2018 Jan 16. Cancer Invest. 2018. PMID: 29336624 Review.

10

Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells.

Zarredar H, Farajnia S, Ansarin K, Baradaran B, Aria M, Asadi M. Zarredar H, et al. Anticancer Agents Med Chem. 2019;19(5):638-644. doi: 10.2174/1871520619666190301125203. Anticancer Agents Med Chem. 2019. PMID: 30827261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page